Premium Subscribers: Complete your KYC to Avoid
Service Suspension. Login Here.

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WANBURY Gains 7%; BSE HEALTHCARE Index Down 0.2%
Thu, 27 Nov 14:56

WANBURY Gains 7%; BSE HEALTHCARE Index Down 0.2%Image source: Eoneren/www.istockphoto.com

WANBURY share price has zoomed 7% and is presently trading at Rs 256.0.

Meanwhile, the BSE HEALTHCARE index is at 44,692.9 (down 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 3.1%) and COHANCE LIFESCIENCES (up 1.5%).

Natco Pharma (down 5.0%) and Abbott India (down 1.8%) are among the top losers today.

Over the last one year, WANBURY has moved up from Rs 223.1 to Rs 256.0, registering a gain of Rs 32.9 (up 14.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 43,384.9 to 44,692.9, registering a gain of 3.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were LAURUS LABS (up 87.7%), NARAYANA HRUDAYALAYA (up 55.4%) and ASTER DM HEALTHCARE (up 52.0%).

Must See: Should You Sell? Hold? Or Buy the Dip?

What About the Benchmark Indices?

The BSE Sensex is at 85,635.4 .

The top gainers among the BSE Sensex today are Bajaj Finance (up 2.1%) and ICICI Bank (up 1.2%). The most traded stocks in the BSE Sensex are HDFC Bank and SBI.

In the meantime, NSE Nifty is at 26,177.9 (down 0.1%). Eicher Motor and Adani Enterprises are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 80,109.9 to 85,635.4, registering a gain of 5,525.5 points (up 6.9%).

WANBURY Financial Update...

WANBURY net profit grew 89.3% YoY to Rs 152 million for the quarter ended September 2025, compared to a profit of Rs 80 million a year ago. Net sales declined 0.7% to Rs 1,601 million during the period as against Rs 1,612 million in July-September 2024.

For the year ended March 2025, WANBURY reported 45.4% decrease in net profit to Rs 305 million compared to net profit of Rs 560 million during FY24. Revenue of the company grew 3.8% to Rs 5,995 million during FY25.

The current Price to earnings ratio of WANBURY, based on rolling 12 month earnings, stands at 17.8.


Equitymaster requests your view! Post a comment on "WANBURY Gains 7%; BSE HEALTHCARE Index Down 0.2%". Click here!